Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common Stock, par value $0.001 per share · CUSIP: 19459J104
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Eventide Asset Management, LLC
Shares: 1,876,239.00 · Class: 5.9%
- Finny Kuruvilla, M.D. Ph. D.
Shares: 1,876,239.00 · Class: 5.9%
- Robin C. John
Shares: 1,876,239.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001580642-26-001061
- Form type
- SCHEDULE 13G/A
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership